GALVANI, FRANCESCA
GALVANI, FRANCESCA
Dipartimento di Scienze degli Alimenti e del Farmaco
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies
2024-01-01 Carullo, G.; Rossi, S.; Giudice, V.; Pezzotta, A.; Chianese, U.; Scala, P.; Carbone, S.; Fontana, A.; Panzeca, G.; Pasquini, S.; Contri, C.; Gemma, S.; Ramunno, A.; Saponara, S.; Galvani, F.; Lodola, A.; Mor, M.; Benedetti, R.; Selleri, C.; Varani, K.; Butini, S.; Altucci, L.; Vincenzi, F.; Pistocchi, A.; Campiani, G.
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions
2023-01-01 Papa, A.; Pasquini, S.; Galvani, F.; Cammarota, M.; Contri, C.; Carullo, G.; Gemma, S.; Ramunno, A.; Lamponi, S.; Gorelli, B.; Saponara, S.; Varani, K.; Mor, M.; Campiani, G.; Boscia, F.; Vincenzi, F.; Lodola, A.; Butini, S.
JAK3 Inhibitors: Covalent and Noncovalent Interactions of a Cyanamide Group Investigated by Multiscale Free-Energy Simulations
2025-01-01 Scalvini, L.; Pala, D.; Cuzzolin, A.; Galvani, F.; Lodola, A.; Rivara, S.; Mor, M.; Rizzi, A.
Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents
2023-01-01 Arafet, Kemel; Scalvini, Laura; Galvani, Francesca; Martí, Sergio; Moliner, Vicent; Mor, Marco; Lodola, Alessio
Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency
2022-01-01 Galvani, F.; Scalvini, L.; Rivara, S.; Lodola, A.; Mor, M.
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity
2023-01-01 Guidetti, Lorenzo; Zappia, Alfonso; Scalvini, Laura; Ferrari, Francesca Romana; Giorgio, Carmine; Castelli, Riccardo; Galvani, Francesca; Vacondio, Federica; Rivara, Silvia; Mor, Marco; Urbinati, Chiara; Rusnati, Marco; Tognolini, Massimiliano; Lodola, Alessio
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach
2023-01-01 Ferrari, Francesca Romana; Giorgio, Carmine; Zappia, Alfonso; Ballabeni, Vigilio; Bertoni, Simona; Barocelli, Elisabetta; Scalvini, Laura; Galvani, Francesca; Mor, Marco; Lodola, Alessio; Tognolini, Massimiliano
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models
2024-01-01 La Monica, Silvia; Vacondio, Federica; Eltayeb, Kamal; Lodola, Alessio; Volta, Francesco; Viglioli, Martina; Ferlenghi, Francesca; Galvani, Francesca; Galetti, Maricla; Bonelli, Mara; Fumarola, Claudia; Cavazzoni, Andrea; Flammini, Lisa; Verzè, Michela; Minari, Roberta; Petronini, Pier Giorgio; Tiseo, Marcello; Mor, Marco; Alfieri, Roberta
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines
2024-01-01 Eltayeb, Kamal; Alfieri, Roberta; Fumarola, Claudia; Bonelli, Mara; Galetti, Maricla; Cavazzoni, Andrea; Digiacomo, Graziana; Galvani, Francesca; Vacondio, Federica; Lodola, Alessio; Mor, Marco; Minari, Roberta; Tiseo, Marcello; La Monica, Silvia; Giorgio Petronini, Pier
Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations
2023-01-01 Galvani, F.; Pala, D.; Cuzzolin, A.; Scalvini, L.; Lodola, A.; Mor, M.; Rizzi, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies | 1-gen-2024 | Carullo, G.; Rossi, S.; Giudice, V.; Pezzotta, A.; Chianese, U.; Scala, P.; Carbone, S.; Fontana, A.; Panzeca, G.; Pasquini, S.; Contri, C.; Gemma, S.; Ramunno, A.; Saponara, S.; Galvani, F.; Lodola, A.; Mor, M.; Benedetti, R.; Selleri, C.; Varani, K.; Butini, S.; Altucci, L.; Vincenzi, F.; Pistocchi, A.; Campiani, G. | |
| Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions | 1-gen-2023 | Papa, A.; Pasquini, S.; Galvani, F.; Cammarota, M.; Contri, C.; Carullo, G.; Gemma, S.; Ramunno, A.; Lamponi, S.; Gorelli, B.; Saponara, S.; Varani, K.; Mor, M.; Campiani, G.; Boscia, F.; Vincenzi, F.; Lodola, A.; Butini, S. | |
| JAK3 Inhibitors: Covalent and Noncovalent Interactions of a Cyanamide Group Investigated by Multiscale Free-Energy Simulations | 1-gen-2025 | Scalvini, L.; Pala, D.; Cuzzolin, A.; Galvani, F.; Lodola, A.; Rivara, S.; Mor, M.; Rizzi, A. | |
| Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents | 1-gen-2023 | Arafet, Kemel; Scalvini, Laura; Galvani, Francesca; Martí, Sergio; Moliner, Vicent; Mor, Marco; Lodola, Alessio | |
| Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency | 1-gen-2022 | Galvani, F.; Scalvini, L.; Rivara, S.; Lodola, A.; Mor, M. | |
| Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity | 1-gen-2023 | Guidetti, Lorenzo; Zappia, Alfonso; Scalvini, Laura; Ferrari, Francesca Romana; Giorgio, Carmine; Castelli, Riccardo; Galvani, Francesca; Vacondio, Federica; Rivara, Silvia; Mor, Marco; Urbinati, Chiara; Rusnati, Marco; Tognolini, Massimiliano; Lodola, Alessio | |
| Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach | 1-gen-2023 | Ferrari, Francesca Romana; Giorgio, Carmine; Zappia, Alfonso; Ballabeni, Vigilio; Bertoni, Simona; Barocelli, Elisabetta; Scalvini, Laura; Galvani, Francesca; Mor, Marco; Lodola, Alessio; Tognolini, Massimiliano | |
| Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models | 1-gen-2024 | La Monica, Silvia; Vacondio, Federica; Eltayeb, Kamal; Lodola, Alessio; Volta, Francesco; Viglioli, Martina; Ferlenghi, Francesca; Galvani, Francesca; Galetti, Maricla; Bonelli, Mara; Fumarola, Claudia; Cavazzoni, Andrea; Flammini, Lisa; Verzè, Michela; Minari, Roberta; Petronini, Pier Giorgio; Tiseo, Marcello; Mor, Marco; Alfieri, Roberta | |
| Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines | 1-gen-2024 | Eltayeb, Kamal; Alfieri, Roberta; Fumarola, Claudia; Bonelli, Mara; Galetti, Maricla; Cavazzoni, Andrea; Digiacomo, Graziana; Galvani, Francesca; Vacondio, Federica; Lodola, Alessio; Mor, Marco; Minari, Roberta; Tiseo, Marcello; La Monica, Silvia; Giorgio Petronini, Pier | |
| Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations | 1-gen-2023 | Galvani, F.; Pala, D.; Cuzzolin, A.; Scalvini, L.; Lodola, A.; Mor, M.; Rizzi, A. |